Daily SPAC Update – April 28, 2025

by | Apr 28, 2025

Rigel Resources Sets Extension Vote. Helathcare AI Extension Vote Today. SPAC IPOs Keep Coming.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

EXTENSION VOTES
HAIA – HEALTHCARE AI ACQUISITION CORP * vote April 28. 2025 -> extend rom May 14, 2025 until October 14, 2025

SPAC DEAL & EXTENSION VOTES SET
RRAC – Rigel Resource Acquisition Corp * EXTENSION VOTE SET: May 08, 2025 * trust $11.84

NEW SPAC IPOs
Apr 24: CHAC – Crane Harbor Acquisition Corp. $200M IPO
Apr 24: IPCX – Inflection Point Acquisition Corp. III $220M IPO
Apr 23: NPAC – New Providence Acquisition Corp. III $261M IPO (+underwriter over-allotment: $39.15M)
Apr 22: TVA – Texas Ventures Acquisition III Corp $200M IPO

SPAC DEALS ANNOUNCED

Apr 23 | CEP – Cantor Equity Partners Inc + Twenty One Capital, Inc.

ABOUT Twenty One Capital, Inc.
At closing, Twenty One will become the first Bitcoin-native public company, built to maximize Bitcoin ownership per share. Twenty One aims to be the most effective public vehicle for Bitcoin accumulation and monetization, with a mission to accelerate Bitcoin adoption and Bitcoin literacy, and a pursuit of strategies to develop a range of Bitcoin-related financial and advisory services.

Apr 23 | VACH – Voyager Acquisition Corp + VERAXA Biotech

ABOUT VERAXA Biotech
At VERAXA Biotech, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including BiTAC antibody-drug conjugates (“BiTAC ADCs”), bispecific T cell engagers (“BiTAC TCEs”), and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, we are rapidly advancing our pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond. VERAXA Biotech was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (“EMBL”), a world-renowned institution known for pioneering life science research and cutting-edge technologies.

SPAC DEAL TERMINATIONS (Last 10 Days)

20205-04-18: FSHP + Great Rich Technologies Limited

SPAC MOVERS

YESTERDAY’S TOP SPAC GAINERS
27.02% ~ $ 31.50 | CEP – CANTOR EQUITY PARTNERS INC (Announced)
14.91% ~ $ 12.41 | BUJA – BUKIT JALIL GLOBAL ACQUISITION 1 LTD (Announced)
8.80% ~ $ 13.10 | DMYY – DMY SQUARED TECHNOLOGY GROUP INC (Pre-Deal)
7.56% ~ $ 11.67 | HCVI – HENNESSY CAPITAL INVESTMENT CORP VI (Announced)
3.71% ~ $ 11.45 | CEPO – CANTOR EQUITY PARTNERS I INC (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-9.95% ~ $ 11.50 | MSSA – METAL SKY STAR ACQUISITION CORP (Pre-Deal)
-5.93% ~ $ 11.43 | DECA – DENALI CAPITAL ACQUISITION CORP (Announced)
-3.25% ~ $ 11.61 | DIST – DISTOKEN ACQUISITION CORP (Announced)
-2.66% ~ $ 16.45 | AIMAU – AIMFINITY INVESTMENT CORP I (Announced)
-2.36% ~ $ 11.18 | YOTA – YOTTA ACQUISITION CORP (Announced)

LATEST SPAC IPO PERFORMANCE
Apr 24 |  | IPCX – Inflection Point Acquisition Corp. III
Apr 23 |  | NPAC – New Providence Acquisition Corp. III
Apr 22 | $ 10.00 | TVA – Texas Ventures Acquisition III Corp
Apr 10 | $ 10.00 | TACH – Titan Acquisition Corp.
Apr 03 | $ 10.00 | SOUL – Soulpower Acquisition Corp.
Apr 03 | $ 10.00 | SZZL – Sizzle Acquisition Corp. II
Apr 01 | $ 10.06 | SDHI – Siddhi Acquisition Corp
Mar 31 | $ 10.08 | UYSC – UY Scuti Acquisition Corp.

Recent Analysis

Daily SPAC Update – April 29, 2025

Black Hawk Deal with Vesicor Therapeutics. Integrated Rail & Resources and Rigel Resource Set Extension Votes. Healthcare AI Acquisition Adjourns Vote to April 30.

Daily SPAC Update – April 21, 2025

Papaya Growth Opportunity (PPYA) + PX Energy Deal Announced. FERA, RAC, LOKV Separate Trading. Globalink and IX Acquisition Amend Merger Agreements.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.